Threshold characteristics of vibration perception through tuning fork vibration measurement in the assessment of lower extremity neuropathy in outpatients at hanoi heart hospital
Main Article Content
Abstract
Background: Diabetic Peripheral Neuropathy (DPN) is a key factor in the causal pathway leading to both foot ulceration and amputation.[1]
Objective: "Characterization of threshold for vibration perception through tuning fork vibration measurement in the assessment of lower extremity neurological complications in outpatients at Hanoi Heart Hospital".
Method: cross-sectional analysis.
Results: The sample size included 205 patients with symptoms of numbness in the legs being treated as outpatients at the medical examination department, Hanoi Heart Hospital; recruited into the study from October 2022 to November 2022; the average age is 65±10 years old, the youngest is 33 years old, the oldest is 92 years old; including 187 patients > 50 years old, accounting for 91.2%; the proportion of men accounted for 46.8% and the rate of women accounted for 53.2%. The highest rates of comorbidities were Hypertension, diabetes and dyslipidemia respectively 89.3%, 85.4% and 81.5%; VPT ≥ 25 has the highest rate: 60.5% on the left side and 59.5% on the right side; for diabetes detection time: the proportion of patients with VPT ≥ 25 mainly in the group of patients with diabetes > 5 years (77.4-78.7%), and a moderate rate (23.7% - 29.3%) in group suffering from 1 to 5 years; The rate of clinical symptoms appearing more frequently in group VPT ≥ 25.
Conclusion: In cases of subclinical use for the diagnosis of neuropathy, a VPT measurement should be performed for the diagnosis and early detection of this pathology in at-risk groups, especially those with diabetes.
Article Details
Keywords
VPT, measuring tuning fork vibration, neuropathy of the lower extremities, diabetis
References
2. Busui R. P., Albers J. W., Feldman L. E. (2014). Peripheral neuropathy in diabetes. Therapy for diabetes mellitus and related disorder. Sixth edition: 793 – 833.
3. Switlyk K.J., Smith A.G. (2016). Update in diabetic peripheral neuropathy. F1000 Research. 5: 1-7.
4. Reiber GE, Vileikyte L, Boyko EJ, et al(1999). Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings.Diabetes Care1999;22: 157–162.
5. Đỗ Đình Tùng, Nguyễn Thị Hạnh, Nguyễn Minh Núi (2022). Nghiên cứu đặc điểm một số chỉ số dẫn truyền thần kinh Ngoại vi chi dưới ở người đái tháo đường típ 2. TẠP CHÍ Y HỌC VIỆT NAM TẬP 521 - THÁNG 12 - SỐ 2 – 2022.
6. Phạm Kiều Anh Thơ(2016). Khảo sát điện dẫn truyền thằn kinh ngoại biên trên bệnh nhân đái tháo đường típ 2”. 84 Ky Yeu Hoi Nghi KHCN Tuoi Tre Cac Truong DHCD Y Duoc Viet Nam Lan Thu XVIII_2016_p338-341.
7. Davies M, Brophy S, Williams R, Taylor A (2006). The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes care 2006;29:1518.
8. Arezzo JC(1999). New developments in the diagnosis of diabetic neuropathy.Am J Med1999;107(Suppl. 2B): 9S–16S.
9. Bril V, Kojic J, Ngo M, Clark K(1997). Comparison of a neurothesiometer and vibratron in measuring vibration perception thresholds and relationship to nerve conduction studies. Diabetes Care 1997;20: 1360–1362.
10. Shy ME, Frohman EM, So YT, et al(2003). Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American academy of neurology.Neurology 2003;60: 898–904.
11. Siao P, Cros DP(2003). Quantitative sensory testing.Phys Med Rehabil Clin N Am2003;14: 261–286.
12. Young MJ, Breddy JL, Veves A, et al(1994). The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds.Diabetes Care1994;17: 557–560.
13. Abbott CA, Vileikyte L, Williamson S,et al(1998). Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998; 21:1071–1075.
13. Diabetes Care 2017. American Diabetes Association. 4.Lifestyle managenment..
14. Diabetes Care. 2010. Executive summary: Standards of medical care in diabetes--2010. Diabetes Care. 2010;33 Suppl 1:S4-10.